Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


11.03.2019

1 Adv Med Sci
1 Am J Physiol Heart Circ Physiol
1 Am J Physiol Regul Integr Comp Physiol
1 Antioxidants (Basel)
1 Biosci Biotechnol Biochem
1 Can J Cardiol
1 Catheter Cardiovasc Interv
1 Chest
1 Circ J
1 Circulation
1 Clin Exp Rheumatol
1 CMAJ
2 Eur Respir J
1 Exp Biol Med (Maywood)
1 Heart
1 Herz
1 Int J Cardiovasc Imaging
1 Int J Mol Sci
1 J Pediatr
1 J Pediatr Ophthalmol Strabismus
1 JAMA Intern Med
1 Lung India
1 PLoS One
1 Respirol Case Rep
1 Surv Ophthalmol
1 Toxicol Appl Pharmacol
1 Transl Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Med Sci

  1. KAZIMIERCZYK R, Kaminski K
    The role of platelets in the development and progression of pulmonary arterial hypertension.
    Adv Med Sci. 2018;63:312-316.
    PubMed     Text format     Abstract available


    Am J Physiol Heart Circ Physiol

  2. YAOITA N, Shimokawa H
    Effect of heart rate reduction in pulmonary arterial hypertension.
    Am J Physiol Heart Circ Physiol. 2018;314:H889-H891.
    PubMed     Text format    


    Am J Physiol Regul Integr Comp Physiol

  3. BECIROVIC-AGIC M, Jonsson S, Tveitaras MK, Skogstrand T, et al
    Time-course of decompensation after angiotensin II and high-salt diet in Balb/CJ mice suggests pulmonary hypertension-induced cardiorenal syndrome.
    Am J Physiol Regul Integr Comp Physiol. 2019.
    PubMed     Text format     Abstract available


    Antioxidants (Basel)

  4. HUETSCH JC, Suresh K, Shimoda LA
    Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension.
    Antioxidants (Basel). 2019;8.
    PubMed     Text format     Abstract available


    Biosci Biotechnol Biochem

  5. MURAKI Y, Naito T, Tohyama K, Shibata S, et al
    Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension.
    Biosci Biotechnol Biochem. 2019 Mar 5:1-11. doi: 10.1080/09168451.2019.1584520.
    PubMed     Text format     Abstract available


    Can J Cardiol

  6. BASYAL B, Jarrett H, Barnett CF
    Pulmonary Hypertension in HIV.
    Can J Cardiol. 2019;35:288-298.
    PubMed     Text format     Abstract available


    Catheter Cardiovasc Interv

  7. YADLAPATI A, Wax D, Rich S, Ricciardi MJ, et al
    Novel shunt modification with an adjustable stent-embedded "fenestrated" septal occluder in a patient with pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Mar 6. doi: 10.1002/ccd.28169.
    PubMed     Text format     Abstract available


    Chest

  8. BRAGANZA M, Shaw J, Solverson K, Vis D, et al
    A prospective evaluation of the diagnostic accuracy of the physical examination for pulmonary hypertension.
    Chest. 2019 Feb 28. pii: S0012-3692(19)30204-1. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    Circ J

  9. SHIBATA A, Mori H, Kodo K, Nakanishi T, et al
    Polysplenia Syndrome as a Risk Factor for Early Progression of Pulmonary Hypertension.
    Circ J. 2019 Mar 5. doi: 10.1253/circj.CJ-18-0933.
    PubMed     Text format     Abstract available


    Circulation

  10. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    PubMed     Text format    


    Clin Exp Rheumatol

  11. PAN J, Lei L, Zhao C
    Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2018;36:1095-1102.
    PubMed     Text format     Abstract available


    CMAJ

  12. PULIGANDLA PS, Skarsgard ED, Offringa M, Adatia I, et al
    Diagnosis and management of congenital diaphragmatic hernia: a clinical practice guideline.
    CMAJ. 2018;190:E103-E112.
    PubMed     Text format    


    Eur Respir J

  13. GRIGNOLA JC, Trujillo P, Domingo E
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    

  14. GERGES C, Gerges M, Lang IM
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    Exp Biol Med (Maywood)

  15. ZHUANG W, Lian G, Huang B, Du A, et al
    Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Exp Biol Med (Maywood). 2018;243:995-1003.
    PubMed     Text format     Abstract available


    Heart

  16. DRAKOPOULOU M, Nashat H, Kempny A, Alonso-Gonzalez R, et al
    Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension.
    Heart. 2018;104:1963-1969.
    PubMed     Text format     Abstract available


    Herz

  17. BERGHAUSEN EM, Feik L, Zierden M, Vantler M, et al
    Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
    Herz. 2019 Mar 7. pii: 10.1007/s00059-019-4795-6. doi: 10.1007/s00059-019-4795.
    PubMed     Text format     Abstract available


    Int J Cardiovasc Imaging

  18. HEKIMSOY V, Kaya EB, Akdogan A, Sahiner L, et al
    Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic scler
    Int J Cardiovasc Imaging. 2018;34:883-892.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  19. SMITS J, Tasev D, Andersen S, Szulcek R, et al
    Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Pediatr

  20. LEE WS, Wong SY, Ivy DD, Sokol RJ, et al
    Hepatopulmonary Syndrome and Portopulmonary Hypertension in Children: Recent Advances in Diagnosis and Management.
    J Pediatr. 2018 Mar 5. pii: S0022-3476(17)31763.
    PubMed     Text format    


    J Pediatr Ophthalmol Strabismus

  21. DANIEL MC, Adams GGW, Dahlmann-Noor A
    Medical Management of Children With Congenital/Infantile Cataract Associated With Microphthalmia, Microcornea, or Persistent Fetal Vasculature.
    J Pediatr Ophthalmol Strabismus. 2019;56:43-49.
    PubMed     Text format     Abstract available


    JAMA Intern Med

  22. LITTMANN L, Potter JK, Hoglund JR
    Profound Electrocardiogram Changes in a Patient With Liver Cirrhosis.
    JAMA Intern Med. 2018;178:286-288.
    PubMed     Text format    


    Lung India

  23. MANJUBASHINI D, Nagarajan K, Rajesh Kumar B
    Pulmonary capillary hemangiomatosis: An unusual cause of primary pulmonary hypertension in a child with characteristic computed tomography imaging features.
    Lung India. 2019;36:157-159.
    PubMed     Text format     Abstract available


    PLoS One

  24. FUJITA N, Yamasaki N, Eto K, Asaeda M, et al
    Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.
    PLoS One. 2018;13:e0204254.
    PubMed     Text format     Abstract available


    Respirol Case Rep

  25. OHASHI K, Nishimura R, Sugimoto S, Sakao S, et al
    Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome.
    Respirol Case Rep. 2019;7:e00411.
    PubMed     Text format     Abstract available


    Surv Ophthalmol

  26. LEWCZUK N, Zdebik A, Boguslawska J, Turno-Krecicka A, et al
    Ocular manifestations of pulmonary hypertension.
    Surv Ophthalmol. 2019 Mar 5. pii: S0039-6257(18)30280.
    PubMed     Text format     Abstract available


    Toxicol Appl Pharmacol

  27. WANG XY, Mo D, Tian W, Liu XX, et al
    Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1alpha-dependent functional TRPC channels.
    Toxicol Appl Pharmacol. 2019 Mar 1. pii: S0041-008X(19)30074.
    PubMed     Text format     Abstract available


    Transl Res

  28. AMBADE AS, Jung B, Lee D, Doods H, et al
    Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation.
    Transl Res. 2019;203:15-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: